FR001400JY13 - Common Stock

**LAT** gets a fundamental rating of **1** out of 10. The analysis compared the fundamentals against 38 industry peers in the **Aerospace & Defense** industry. **LAT** may be in some trouble as it scores bad on both profitability and health. **LAT** is quite expensive at the moment. It does show a decent growth rate.

In the past year **LAT** has reported a negative cash flow from operations.

In the past 5 years **LAT** reported 4 times negative net income.

In the past 5 years **LAT** reported 4 times negative operating cash flow.

Looking at the **Return On Assets**, with a value of **-17.69%**, **LAT** is doing worse than **91.89%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -17.69% | ||

ROE | N/A | ||

ROIC | N/A |

ROA(3y)-23.52%

ROA(5y)-14.95%

ROE(3y)-396.82%

ROE(5y)-240.93%

ROIC(3y)N/A

ROIC(5y)N/A

The **Gross Margin** of **LAT** (**36.63%**) is comparable to the rest of the industry.

In the last couple of years the **Gross Margin** of **LAT** has remained more or less at the same level.

The **Profit Margin** and **Operating Margin** are not available for **LAT** so they could not be analyzed.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | N/A | ||

PM (TTM) | N/A | ||

GM | 36.63% |

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y3.07%

GM growth 5Y-0.89%

Compared to 1 year ago, **LAT** has more shares outstanding

Compared to 5 years ago, **LAT** has more shares outstanding

Based on the Altman-Z score of **-0.36**, we must say that **LAT** is in the distress zone and has some risk of bankruptcy.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | N/A | ||

Debt/FCF | N/A | ||

Altman-Z | -0.36 |

ROIC/WACCN/A

WACC4.83%

Looking at the **Quick ratio**, with a value of **0.47**, **LAT** is doing worse than **89.19%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 0.99 | ||

Quick Ratio | 0.47 |

The **Earnings Per Share** has grown by an impressive **39.96%** over the past year.

The **Revenue** has grown by **41.00%** in the past year. This is a very strong growth!

The **Revenue** has been decreasing by **-6.56%** on average over the past years.

EPS 1Y (TTM)39.96%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q77.95%

Revenue 1Y (TTM)41%

Revenue growth 3Y-13.08%

Revenue growth 5Y-6.56%

Revenue growth Q2Q43.01%

The **Revenue** is expected to grow by **18.87%** on average over the next years. This is quite good.

EPS Next Y-134.59%

EPS Next 2Y-45.86%

EPS Next 3Y-22.87%

EPS Next 5YN/A

Revenue Next Year32.83%

Revenue Next 2Y24.05%

Revenue Next 3Y18.87%

Revenue Next 5YN/A

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

Also next year **LAT** is expected to report negative earnings again, which makes the also the **Forward Price/Earnings** Ratio negative.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | N/A |

Compared to the rest of the industry, the **Enterprise Value to EBITDA** ratio of **LAT** indicates a rather expensive valuation: **LAT** more expensive than 81.08% of the companies listed in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | N/A | ||

EV/EBITDA | 48.84 |

A cheap valuation may be justified as **LAT**'s earnings are expected to decrease with **-22.87%** in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-45.86%

EPS Next 3Y-22.87%

No dividends for **LAT**!.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

**LATECOERE**

EPA:LAT (4/19/2024, 7:00:00 PM)

**0.013**

**+0 (+0.78%) **

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryAerospace & Defense

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap162.04M

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | N/A | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -17.69% | ||

ROE | N/A | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | N/A | ||

PM (TTM) | N/A | ||

GM | 36.63% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.65

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | N/A | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 0.99 | ||

Quick Ratio | 0.47 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)39.96%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y-134.59%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)41%

Revenue growth 3Y-13.08%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y